Friday 26th November 2021

Nepal Receives ‘USD 165 Million Loan’ from ADB for COVID-19 Vaccines!

The fund will help Nepal procure around 15.9 million vaccine doses, sufficient to inoculate about 6.8 million Nepalis.
Coronavirus

News

US-Nepalis

 
Nepal Receives ‘USD 165 Million Loan’ from ADB for COVID-19 Vaccines!

Nepali Government has received approval for a loan of USD 165 million from the Asian Development Bank (ADB) to procure COVID-19 vaccines.

The fund will support Nepal’s National Deployment and Vaccination Plan and help procure around 15.9 million doses of COVID-19 vaccines, sufficient enough to inoculate about 6.8 million Nepalis.

“ADB’s support will help the Nepali Government procure much-needed COVID-19 vaccines to protect its citizens from the further spread of this disease,” mentioned ADB President Masatsugu Asakawa.

 

“It is essential that COVID-19 vaccines are quickly purchased and administered to help get the economy back on track by enabling the restoration of livelihoods and economic activities, as well as the resumption of educational and human development pursuits,” he added.

The ADB has offered support to Nepal through its USD 9 billion Asia Pacific Vaccine Access Facility launched in December 2020. The Facility aims at providing prompt and equitable vaccine-related support to ADB developing member countries.

Asia Pacific Vaccine Access

However, the ADB’s fund must be used for vaccines that meet at least one of the  APVAX eligibility criteria:

  • The vaccine must be selected for procurement through the COVID-19 Vaccines Global Access (COVAX) mechanism
  • The vaccine must be pre-qualified by the WHO
  • The vaccine must receive regular or emergency authorization by a Stringent Regulatory Authority

Stay Tuned to NepaliSansar for Latest Nepal COVID-19 Updates!


More News:

July 23, 2021 |

 
The buddha life journey and significance
 
 

 

Subscribe to our Newsletter

Sign up for more inspiring latest news, events, tourism, and more from Nepalisansar.